Brief: Prostatype Genomics Updates On Progress With Prostatype Study
17/04/2024 12:12
April 17 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* UPDATES ON SIGNIFICANT PROGRESS IN THE US STUDY WITH
PROSTATYPE®
* EXPECTS TO SUBMIT MEDICARE APPLICATION IN Q2-Q3 2024 AND
RECEIVE
APPROVAL IN Q4 2024
Source text for Eikon: ID:nWkr7mHpCX
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants